Zobrazeno 1 - 10
of 836
pro vyhledávání: '"Arellano, Ml"'
Autor:
Hoff FW; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX., Blum WG; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA., Huang Y; Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH., Welkie RL; Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH., Swords RT; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR., Traer E; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR., Stein EM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Lin TL; Department of Internal Medicine, The University of Kansas Medical Center, Kansas City, KS., Archer KJ; Division of Biostatistics, The Ohio State University, Columbus, OH., Patel PA; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX., Collins RH; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX., Baer MR; Department of Medicine, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD., Duong VH; Department of Medicine, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD., Arellano ML; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA., Stock W; Department of Medicine, The University of Chicago, Chicago, IL., Odenike O; Department of Medicine, The University of Chicago, Chicago, IL., Redner RL; Department of Medicine, University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA., Kovacsovics T; Division of Hematology and Hematologic Malignancies, The University of Utah, Salt Lake City, UT., Deininger MW; Department of Internal Medicine, Versiti Blood Research Institute and Medical College of Wisconsin, Milwaukee, WI., Zeidner JF; Division of Hematology, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Olin RL; Department of Medicine, University of California, San Francisco, San Francisco, CA., Smith CC; Department of Medicine, University of California, San Francisco, San Francisco, CA., Foran JM; Department of Internal Medicine, Mayo Clinic, Jacksonville, FL., Schiller GJ; Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA., Curran EK; Deparrtment of Internal Medicine, University of Cincinnati, Cincinnati, OH., Koenig KL; Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH., Heerema NA; Department of Pathology, The Ohio State University, Columbus, OH., Chen T; Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH., Martycz M; Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH., Stefanos M; Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH., Marcus SG; Leukemia & Lymphoma Society, Rye Brook, NY., Rosenberg L; Leukemia & Lymphoma Society, Rye Brook, NY., Druker BJ; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR., Levine RL; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Burd A; Leukemia & Lymphoma Society, Rye Brook, NY., Yocum AO; Leukemia & Lymphoma Society, Rye Brook, NY., Borate UM; Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH., Mims AS; Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH., Byrd JC; Deparrtment of Internal Medicine, University of Cincinnati, Cincinnati, OH., Madanat YF; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX.
Publikováno v:
Blood advances [Blood Adv] 2024 Oct 22; Vol. 8 (20), pp. 5297-5305.
Autor:
DiNardo CD; Department of Leukemia, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX., Roboz GJ; Clinical and Translational Leukemia Programs, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY., Watts JM; Division of Hematology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL., Madanat YF; Division of Hematology and Oncology, UT Southwestern Medical Center, Dallas, TX., Prince GT; Division of Hematologic Malignancy, Johns Hopkins Hospital, Baltimore, MD., Baratam P; Division of Hematology and Oncology, Medical University of South Carolina, Charleston, SC., de Botton S; Hematologie Clinique, Institut Gustave Roussy, Villejuif, Faculté Paris-Saclay, Institut Gustave Roussy, Villejuif, France., Stein A; Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA., Foran JM; Division of Hematology & Medical Oncology, Mayo Clinic, Jacksonville, FL., Arellano ML; Department of Hematology and Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA., Sallman DA; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL., Hossain M; Servier Pharmaceuticals, LLC, Boston, MA., Marchione DM; Servier Pharmaceuticals, LLC, Boston, MA., Bai X; Servier Pharmaceuticals, LLC, Boston, MA., Patel PA; Servier Pharmaceuticals, LLC, Boston, MA., Kapsalis SM; Servier Pharmaceuticals, LLC, Boston, MA., Garcia-Manero G; Department of Leukemia, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX., Fathi AT; Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
Publikováno v:
Blood advances [Blood Adv] 2024 Aug 13; Vol. 8 (15), pp. 4209-4220.
Autor:
Shah BD; Division of Hematology/Oncology, Department of Malignant Hematology, Moffitt Cancer Center, Tampa, Florida, USA Bijal.Shah@moffitt.org., Cassaday RD; Fred Hutchinson Cancer Center, University of Washington, Seattle, Washington, USA., Park JH; Department of Medicine, Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Houot R; Department of Hematology, CHU Rennes, University Hospital Rennes, Inserm & EFS, Rennes, France., Oluwole OO; Vanderbilt-Ingram Cancer Center, Division of Hematology and Oncology, Vanderbilt University, Nashville, Tennessee, USA., Logan AC; Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA., Boissel N; Département d'Hématologie Clinique, Hôpital Saint-Louis, Paris, France., Leguay T; Department of Hematology, Service d'hématologie clinique et thérapie cellulaire Hôpital du Haut-Leveque CHU de Bordeaux, Bordeaux, France., Bishop MR; The David and Etta Jonas Center for Cellular Therapy, The University of Chicago Medicine, Chicago, Illinois, USA., Topp MS; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Wurzburg, Germany., Tzachanis D; Moores Cancer Center, University of California San Diego, San Diego, California, USA., O'Dwyer KM; Wilmot Cancer Institute, University of Rochester, Rochester, New York, USA., Arellano ML; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA., Lin Y; Department of Hematology, Mayo Clinic, Rochester, Minnesota, USA., Baer MR; Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, USA., Schiller GJ; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Subklewe M; Department of Medicine III, Ludwig-Maximilians-Universität München, Munich, Germany., Abedi M; Davis Comprehensive Cancer Center, University of California, Sacramento, California, USA., Minnema MC; Department of Hematology, University Medical Centre Utrecht, Utrecht, The Netherlands., Wierda WG; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Stiff PJ; Department of Hematology/Oncology, Loyola University Medical Center, Maywood, Illinois, USA., Jeyakumar D; Chao Comprehensive Cancer Center, University of California Irvine Medical Center, Irvine, California, USA., Mao D; Kite, a Gilead Company, Santa Monica, California, USA., Adhikary S; Kite, a Gilead Company, Santa Monica, California, USA., Zhou L; Kite, a Gilead Company, Santa Monica, California, USA., Schuberth PC; Kite, a Gilead Company, Santa Monica, California, USA., Damico Khalid R; Kite, a Gilead Company, Santa Monica, California, USA., Ghobadia A; Division of Medical Oncology, Washington University School of Medicine in Saint Louis, St Louis, Missouri, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Aug; Vol. 11 (8).
Autor:
Duong VH; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA., Ruppert AS; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA., Mims AS; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA., Borate U; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA., Stein EM; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Baer MR; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA., Stock W; Section of Hematology/Oncology, University of Chicago, Chicago, Illinois, USA., Kovacsovics T; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah, USA., Blum W; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA., Arellano ML; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA., Schiller GJ; David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California, USA., Olin RL; Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California, USA., Foran JM; Hematology and Oncology, Mayo Clinic, Jacksonville, Florida, USA., Litzow MR; Departments of Medical Oncology, Hematology, and Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Lin TL; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA., Patel PA; University of Texas Southwestern Medical Center Medical School, Dallas, Texas, USA., Foster MC; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA., Redner RL; Hillman Cancer Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Al-Mansour Z; Department of Medicine, University of Florida, Gainesville, Florida, USA., Cogle CR; Department of Medicine, University of Florida, Gainesville, Florida, USA., Swords RT; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA., Collins RH; University of Texas Southwestern Medical Center Medical School, Dallas, Texas, USA., Vergilio JA; Foundation Medicine, Cambridge, Massachusetts, USA., Heerema NA; Department of Pathology, College of Medicine, The Ohio State University, Columbus, Ohio, USA., Rosenberg L; The Leukemia & Lymphoma Society, Rye Brook, New York, USA., Yocum AO; The Leukemia & Lymphoma Society, Rye Brook, New York, USA., Marcus S; The Leukemia & Lymphoma Society, Rye Brook, New York, USA., Chen T; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA., Druggan F; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA., Stefanos M; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA., Gana TJ; Biopharmatech Consulting, Inc., Leesburg, Virginia, USA., Shoben AB; Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, Ohio, USA., Druker BJ; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA., Burd A; The Leukemia & Lymphoma Society, Rye Brook, New York, USA., Byrd JC; Internal Medicine, University of Cincinnati, Cincinnati, Ohio, USA., Levine RL; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Boyiadzis MM; Hillman Cancer Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Publikováno v:
Cancer [Cancer] 2023 Aug 01; Vol. 129 (15), pp. 2308-2320. Date of Electronic Publication: 2023 Apr 20.
Autor:
Saliba AN; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Kaufmann SH; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN.; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN., Stein EM; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Patel PA; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX., Baer MR; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD., Stock W; Department of Medicine, Section of Hematology Oncology, University of Chicago, Chicago, IL., Deininger M; Division of Hematology and Oncology, Department of Medicine, University of Utah Huntsman Cancer Institute, Salt Lake City, UT., Blum W; Winship Cancer Institute of Emory University, Atlanta, GA., Schiller GJ; David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA., Olin RL; University of California, San Francisco, San Francisco, CA., Litzow MR; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Lin TL; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS., Ball BJ; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Boyiadzis MM; University of Pittsburgh Hillman Cancer Center, Pittsburgh, PA., Traer E; Knight Cancer Institute, Oregon Health & Science University, Portland, OR., Odenike O; Department of Medicine, Section of Hematology Oncology, University of Chicago, Chicago, IL., Arellano ML; Winship Cancer Institute of Emory University, Atlanta, GA., Walker A; The Ohio State University, Columbus, OH., Duong VH; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD., Kovacsovics T; Division of Hematology and Oncology, Department of Medicine, University of Utah Huntsman Cancer Institute, Salt Lake City, UT., Collins RH; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX., Shoben AB; The Ohio State University, Columbus, OH., Heerema NA; The Ohio State University, Columbus, OH., Foster MC; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC., Peterson KL; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN., Schneider PA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN., Martycz M; The Ohio State University, Columbus, OH., Gana TJ; Biopharmatech Consulting, Inc., Leesburg, VA., Rosenberg L; Leukemia and Lymphoma Society, White Plains, NY., Marcus S; Leukemia and Lymphoma Society, White Plains, NY., Yocum AO; Leukemia and Lymphoma Society, White Plains, NY., Chen T; The Ohio State University, Columbus, OH., Stefanos M; The Ohio State University, Columbus, OH., Mims AS; The Ohio State University, Columbus, OH., Borate U; The Ohio State University, Columbus, OH., Burd A; Leukemia and Lymphoma Society, White Plains, NY., Druker BJ; Knight Cancer Institute, Oregon Health & Science University, Portland, OR., Levine RL; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Byrd JC; Department of Medicine, University of Cincinnati, Cincinnati, OH., Foran JM; Division of Hematology-Oncology, Department of Medicine, Mayo Clinic, Jacksonville, FL.
Publikováno v:
Blood advances [Blood Adv] 2023 Jun 13; Vol. 7 (11), pp. 2360-2363.
Autor:
Arellano ML, Serrano CB, Guedea M, Garcia Pérez JC, Ortega GS, Guevara-Martinez J, Gomez Abril S, González Puga C, Arroyo A, Cantero Cid R
Publikováno v:
ADVANCES IN SKIN & WOUND CARE
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO. Repositorio Institucional de Producción Científica
instname
BACKGROUND: Global studies indicate that surgical site infections (SSIs) are a major healthcare challenge within hospitals and can have a profound impact on patient quality of life and healthcare costs. Closed-incision negative-pressure therapy (ciNP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::d242ab0989dc828dd9d11eede420381e
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=11901
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=11901
Autor:
Shah BD; Moffitt Cancer Center, Tampa, FL, 33612, USA. bijal.shah@moffitt.org., Ghobadi A; Washington University School of Medicine, St Louis, MO, USA., Oluwole OO; Vanderbilt University Cancer Center, Nashville, TN, USA., Logan AC; UCSF Medical Center, San Francisco, CA, USA., Boissel N; Hôpital Saint-Louis, Paris, France., Cassaday RD; University of Washington, Fred Hutchinson Cancer Center, Seattle, WA, USA., Leguay T; Service d'hématologie Clinique Et Thérapie Cellulaire, Hopital du Haut-Leveque CHU de Bordeaux, Bordeaux, France., Bishop MR; The University of Chicago Medicine, Chicago, IL, USA., Topp MS; Medizinische Klinik Und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany., Tzachanis D; University of California San Diego, San Diego, CA, USA., O'Dwyer KM; Wilmot Cancer Institute of University of Rochester, Rochester, NY, USA., Arellano ML; Winship Cancer Institute of Emory University, Atlanta, GA, USA., Lin Y; Mayo Clinic, Rochester, MN, USA., Baer MR; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Schiller GJ; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Park JH; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Subklewe M; Ludwig-Maximilians-Universität München, Munich, Germany., Abedi M; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA., Minnema MC; University Medical Center Utrecht (on behalf of HOVON/LLPC), Utrecht, The Netherlands., Wierda WG; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., DeAngelo DJ; Dana-Farber Cancer Institute, Boston, MA, USA., Stiff P; Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA., Jeyakumar D; University of California Irvine Medical Center, Orange, CA, USA., Dong J; Kite, a Gilead Company, Santa Monica, CA, USA., Adhikary S; Kite, a Gilead Company, Santa Monica, CA, USA., Zhou L; Kite, a Gilead Company, Santa Monica, CA, USA., Schuberth PC; Kite, a Gilead Company, Santa Monica, CA, USA., Faghmous I; Kite, a Gilead Company, Santa Monica, CA, USA., Masouleh BK; Kite, a Gilead Company, Santa Monica, CA, USA., Houot R; CHU Rennes, Univ Rennes, Inserm & EFS, Rennes, France.
Publikováno v:
Journal of hematology & oncology [J Hematol Oncol] 2022 Dec 10; Vol. 15 (1), pp. 170. Date of Electronic Publication: 2022 Dec 10.
Autor:
Coccolini F, Register of Open Abdomen (IROA)., Ceresoli, M, Kluger, Y, Kirkpatrick, A, Montori, G, Salvetti, F, Fugazzola, P, Tomasoni, M, Sartelli, M, Ansaloni, L1, Catena, F, Nego, I, Zese, M, Occhionorelli, S, Shlyapnikov, S, Galatioto, C, Chiarugi, M, Demetrashvili, Z, Dondossola, D, Ioannidis, O, Novelli, G, Nacoti, M, Khor, D, Inaba, K, Demetriades, D, Kaussen, T, Jusoh, Ac, Ghannam, W, Sakakushev, B, Guetta, O, Dogjani, A, Costa, S, Singh, S, Damaskos, D, Ardaisik, Yuan, Kc, Trotta, F, Rausei, S, Martinez-Perez, A, Bellanova, G, Fonseca, V, Hernández, F, Marinis, A, Fernandes, W, Quiodettis, M, Bala, M, Vereczkei, A, Curado, R, Fraga, Gp, Pereira, Bm, Gachabayov, M, Chagerben, Gp, Arellano, Ml, Ozyazici, S, Costa, G, Tezcaner, T, Porta, M, Li, Y, Karateke, F, Manatakis, D, Mariani, F, Lora, F, Sahderov, I, Atanasov, B, Zegarra, S, Gianotti, L, Fattori, L, Ivatury, R, IROA study group
Introduction No definitive data describing associations between cases of Open Abdomen (OA) and Entero-atmospheric fistulae (EAF) exist. The World Society of Emergency Surgery (WSES) and the Panamerican Trauma Society (PTS) thus analyzed the Internati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4e9a55094646b07086acdd5cc6aff8a
http://hdl.handle.net/11392/2398046
http://hdl.handle.net/11392/2398046
Autor:
Pollyea DA; Division of Hematology, School of Medicine, University of Colorado, Aurora, Colorado., DiNardo CD; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Arellano ML; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia., Pigneux A; Department of Hematology, CHU de Bordeaux, Bordeaux, France., Fiedler W; Department of Hematology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Konopleva M; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Rizzieri DA; Novant Health Cancer Institute, Charlotte, Durham, North Carolina., Smith BD; Department of Oncology, Johns Hopkins Medicine, Baltimore, Maryland., Shinagawa A; Department of Hematology, Hitachi General Hospital, Hitachi-shi, Japan., Lemoli RM; Clinic of Hematology, Department of Internal Medicine, University of Genoa, Genoa, Italy.; San Martino Hospital IRCCS, Genoa, Italy., Dail M; Genentech Inc., South San Francisco, California., Duan Y; AbbVie Inc., North Chicago, Illinois., Chyla B; AbbVie Inc., North Chicago, Illinois., Potluri J; AbbVie Inc., North Chicago, Illinois., Miller CL; AbbVie Inc., North Chicago, Illinois., Kantarjian HM; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Jul 01; Vol. 28 (13), pp. 2753-2761.
Autor:
Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Begna KH; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Altman JK; Department of Medicine, Northwestern University, Chicago, Illinois., Goldberg SL; Hackensack University Medical Center, Hackensack, New Jersey., Sekeres MA; Hematologic Oncology and Blood Disorders, Cleveland Clinic, Cleveland, Ohio., Strickland SA; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee., Arellano ML; Hematology/Oncology, Emory University School of Medicine, Atlanta, Georgia., Claxton DF; Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania., Baer MR; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland., Gautier M; Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire., Berman E; Memorial Sloan Kettering Cancer Center, New York, New York., Seiter K; Department of Medicine, New York Medical College, Valhalla, New York., Solomon SR; Northside Hospital Cancer Institute, Leukemia Program, Atlanta, Georgia., Schiller GJ; Hematological Malignancy/Stem Cell Transplant Program, David Geffen School of Medicine at the University of California, Los Angeles, California., Luger SM; Department of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Butrym A; Department of Hematology, Blood Neoplasms, and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland., Gaidano G; Division of Hematology, Maggiore della Carita University Hospital, Novara, Italy., Thomas XG; Hematology, South Hospital Center, Lyon, France., Montesinos P; La Fe University and Polytechnic Hospital, Valencia, Spain., Rizzieri DA; Department of Medicine, Duke University Medical Center, Durham, North Carolina., Quick DP; Joe Arrington Cancer Center, Lubbock, Texas., Venugopal P; Department of Medicine, Hematology, and Oncology, Rush University Medical Center, Chicago, Illinois., Gaur R; St Luke's Cancer Institute, Kansas City, Missouri., Maness LJ; Division of Hematology-Oncology Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Buyse ME; International Drug Development Institute, Louvain-la-Neuve, Belgium., Chiao JH; Cyclacel Limited, Dundee, United Kingdom.
Publikováno v:
Cancer [Cancer] 2021 Dec 01; Vol. 127 (23), pp. 4421-4431. Date of Electronic Publication: 2021 Aug 23.